Articles & Video
Parexel $8.5bn takeover prompted by large pharma customers
Parexel’s soon-to-be owners EQT Private Equity and Goldman Sachs Asset Management cited growth and large pharma and biotech customer base as drivers for the takeover.
Think buys BioPharma Services to expand digital CRO business
Cloud trial software firm Think Research Corp has announced plans to buy fellow Canada-based CRO BioPharma Services.
WCG expands capabilities through Intrinsic Imaging acquisition
WCG will increase its scientific and regulatory capabilities through the acquisition of Intrinsic Imaging.
CTI buys Spain’s Dynakin to further support customers in EU and MEA
CTI Clinical Trial and Consulting Services has acquired Spanish CRO Dynakin to support its customers in Europe, the Middle East and Africa.
dMed-Clinipace raises $50m for integration and expansion
dMed-Clinipace says $50 million from a recent fundraising round has been used to finance ongoing integration efforts and global expansion.
WCG sees falling R&D and trial productivity as a major opportunity
IPO-ready WCG Clinical says low R&D productivity rates are an opportunity for a firm with the right mix of technology and knowhow.
CMIC opts for Lokavant’s machine learning tech to predict trial risk
Clinical trial intelligence firm Lokavant will provide Japan’s CMIC with analytics support for studies under a new multi-year partnership.
Alira acquires CROS NT citing biometrics and presence in EU
Alira Health has acquired ‘data-driven’ contract research firm CROS NT in a deal intended to bolster its biometrics offering.
Genentech teams with trial sites to boost diversity in cancer studies
Genentech has teamed with a network of clinical research sites to try and ensure its cancer drug trials include a more diverse group of patients.
Medidata launches decentralized clinical trials program
COVID-19 has highlighted the need for decentralized clinical trials, says Medidata as it launches a direct patient data capture technology.
Medable rolls out decentralized trial tech it claims can speed recruitment and cut sites
Medable claims its digital certification software and training program can help drug firms and CROs take full advantage of decentralized trials.
COVID-19 prompted close working relationship with IRB, IRC provider says IQVIA
IQVIA says its novel partnership with Advarra helped it meet COVID-19 vaccine and therapeutic developers’ demands for shorter timelines.
Clinical data management innovation needed to reduce mid-study updates
CROs need to improve trial data management according to analysis, which suggests disruptive mid-study database updates are increasingly common.
Evotec to set up service to speed drug R&D in future pandemics
Evotec has set up a “pre-competitive” initiative to support customers’ drug and vaccine R&D efforts in the event of future pandemics.
Cancer drug trials getting harder due to demand and growing complexity, Tufts
Cancer trials are getting harder according to Tufts, which says increasing scale and complexity combined with the focus on subpopulations have increased the risk of undertaking such research.
Enzymatic printer will speed R&D and COVID testing, says DNA Script
DNA Script has launched a benchtop nucleic acid printer it claims will accelerate molecular biology, genomic research, and even COVID-19 testing.
Icon aims to raise $2bn through share offer to part fund PRA takeover
Icon plans to raise $2 billion to help fund the planned $12 billion acquisition of PRA Health Sciences.
Medidata launches tech to tackle patient engagement issues
Medidata aims to increase engagement and awareness for patients before and after clinical trials with the launch of myMedidata Registries.
Trial productivity flat in 2020 but efficiency efforts show promise, IQVIA
Clinical development productivity climbed only slightly in 2020 according to IQVIA’s Institute for human data science, which says longer trials and biopharma’s focus on more complex are the key dynamics.